Boai NKY Medical Holdings Ltd. (SHE:300109)

Market Cap	8.47B +16.5%
Revenue (ttm)	1.20B -22.2%
Net Income	174.42M -43.5%
EPS	0.35 -44.8%
Shares Out	483.38M
PE Ratio	49.59
Forward PE	n/a
Dividend	0.20 (1.11%)
Ex-Dividend Date	Jul 10, 2025

Volume	9,270,213
Average Volume	11,925,209
Open	19.06
Previous Close	18.02
Day's Range	17.50 - 19.06
52-Week Range	15.76 - 21.11
Beta	0.20
RSI	34.55
Earnings Date	Apr 24, 2026

About Boai NKY Medical Holdings

Boai NKY Medical Holdings Ltd. engages in the fine chemical and precision medicine businesses in China and internationally. The company produces and sells polyvinyl pyrrolidone (PVP), Orarez, and in vitro diagnostic products, as well as invests in tumor drugs. It offers its products for pharmaceutical products, such as APIs and excipients; personal care products, including cosmetics, haircare, oral care, and household care; alcohol, soft drinks, and food; battery, petroleum and natural gas, and photovoltaic; and membrane, textile and dyeing, ag...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 1987
• Employees: 1,186
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300109

Financial Performance

In 2025, Boai NKY Medical Holdings's revenue was 1.18 billion, a decrease of -26.66% compared to the previous year's 1.61 billion. Earnings were 190.09 million, a decrease of -45.64%.